TELA Bio, Inc. Share Price & Technical Analysis
TELA · $0.89 (-3.26%)
Healthcare / Medical Devices
$0.89
-3.26%
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue …
Price chart
Seasonality
May has 3 positive and 1 negative years (last 5 years shown)
0% return in May, 23% avg return in past 3 year May month.
-31% return in 2026, -57% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -17% | -10% | -33% | 29% | 0% | – | – | – | – | – | – | – | -31% |
| 25 | -13% | -4% | -50% | -17% | 40% | 36% | -15% | 6% | -17% | -20% | -8% | 0% | -62% |
| 24 | 5% | -3% | -16% | -21% | 20% | -16% | -6% | -34% | -11% | 12% | 11% | -6% | -67% |
| 23 | 4% | -10% | 0% | -11% | 9% | 0% | -3% | -1% | -18% | -27% | -10% | 27% | -42% |
| 22 | -2% | 5% | -9% | -18% | -24% | 1% | 16% | 6% | 0% | 3% | -7% | 37% | 8% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$50.59M
P/E ratio
—
52W high
$2.20
52W low
$0.50
Volume
95,667
Beta
1.30
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is TELA Bio, Inc. share price today?
- TELA Bio, Inc. (TELA) last traded around $0.89 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TELA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TELA. Download the app for real-time alerts.
- How can I analyze TELA Bio, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.